Thymosin beta 4 is associated with collateral development in coronary artery disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thymosin beta 4 is associated with collateral development in coronary artery disease

Published:2011-08-30 Issue:8 Volume:71 Page:625-630
ISSN:0036-5513
Container-title:Scandinavian Journal of Clinical and Laboratory Investigation
language:en
Short-container-title:Scandinavian Journal of Clinical and Laboratory Investigation

Author:

Biçer Asuman,Karakurt Özlem,Akdemir Ramazan,Erden Gönül,Yildiz Ali,Özcan Özge,Sezen Yusuf,Açikel Sadik,Kiliç Harun,DemirbaG Recep

Publisher

Informa UK Limited

Subject

Clinical Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/00365513.2011.599417

Reference22 articles.

1. Physiologically assessed coronary collateral flow and adverse cardiac ischemic events: a follow-up study in 403 patients with coronary artery disease

2. Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators.

3. Coronary collateral circulation: Clinical significance and influence on survival in patients with coronary artery occlusion

4. Beneficial Effect of Recruitable Collaterals

5. Collateralization and the response to obstruction of epicardial coronary arteries

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thymosin β4 and the anti-fibrotic switch;International Immunopharmacology;2023-02

2. Thymosin β4: potential to treat epidermolysis bullosa and other severe dermal injuries;European Journal of Dermatology;2019-10

3. Thymosin β4-mediated protective effects in the heart;Expert Opinion on Biological Therapy;2018-05-31

4. Thymosin Beta‐4 Is Elevated in Women With Heart Failure With Preserved Ejection Fraction;Journal of the American Heart Association;2017-11-06

5. Systemic Dosing of Thymosin Beta 4 before and after Ischemia Does Not Attenuate Global Myocardial Ischemia-Reperfusion Injury in Pigs;Frontiers in Pharmacology;2016-05-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3